Yeasts are tiny powerhouses. They've been helping humans make bread, beer, and wine for ages. Now, scientists are using them to make medicines too. One such yeast, Kluyveromyces lactis, is known for its work in the dairy industry. But now, it's being used in a new way. Scientists have developed a method to use this yeast to make proteins without needing the whole cel...
Texas has taken a bold step by suing Tylenol's maker, Kenvue, and its former owner, Johnson & Johnson. The lawsuit claims these companies misled the public about Tylenol's safety during pregnancy. The main concern? A possible link between Tylenol and developmental issues like autism and ADHD. The lawsuit, filed in Texas, argues that the companies knew about potentia...
The 15th European Immunogenicity Platform Open Symposium took place in Lisbon from February 22-24, 2024. This event brought together professionals from various fields, including industry, regulatory bodies, and academia. They gathered to discuss the challenges posed by the immune response to biopharmaceuticals. In simple terms, these are medicines made from living...
In Scotland, researchers took a close look at how chiral drugs make their way into rivers. They spent a year studying five community septic tanks. The goal was to figure out how these tanks affect the amounts and types of chiral drugs that end up in nearby rivers. The study focused on 25 different chiral drugs and their byproducts. These drugs can be found in both en...
Making drugs that are packed into tiny lipid bubbles, called liposomes, is a big deal in medicine. Usually, this process needs a lot of heat, which costs a lot of energy and time. Plus, it can mess up the drugs and the bubbles. But, what if there's a way to do it without all that heat? Scientists found a clever way to pack a drug called doxorubicin into lipo...
In recent years, the biopharmaceutical industry has seen a significant shift. Chinese companies are now at the forefront of developing innovative drugs. This trend has caught the attention of U. S. pharmaceutical giants, who are increasingly looking to China for promising new treatments. One notable example is the experimental cancer drug developed by a Chinese comp...
Baden-Wuerttemberg, a region in Germany, is exploring ways to grow medicinal plants. This is not just about picking plants that can easily grow there, but also about looking at the bigger picture. They are using a tool called SWOT analysis. It stands for Strengths, Weaknesses, Opportunities, and Threats. This tool helps them figure out which plants will do well in t...
Creating stable formulations for biopharmaceuticals like infliximab is no easy task. Scientists explored using 2-hydroxypropyl-β-cyclodextrin (HP-β-CD) to keep infliximab from degrading. They made both liquid and solid formulations. For the solid version, they used a scaled-up high-speed electrospinning technique to create a product that dissolves well. The liquid fo...
Ever wondered how pharmaceuticals disappear from soils over time? Scientists have created a new mathematical model to figure out the answer. This clever tool treats soil particles like tiny balls, considering how tightly pollutants stick to them (called sorption) and how they break down (or dissipate). The model looks at three main ways pharmaceuticals vanish: first...
Biopharmaceuticals are on the rise, but they have a big problem—they tend to clump together quickly. Right now, we use surfactants like polysorbates and poloxamers to stop this from happening and make them last longer. However, these surfactants aren't very stable themselves. They change into many different compounds over time, and some of these can cause serious sid...